Celia Belline, CILcare’s CEO, and Lise Byelyayeva, Business Developer, will be attending this year’s BIO International Conference in San Diego, CA, on June 13-16. CILcare’s team is looking forward to meeting innovative actors to discuss their current and future projects, as well as innovation in hearing disorders treatment.
BIO International Conference gathers innovative actors from the life science industry and academia to connect and to create opportunities.
CILcare is the world-leading R&D services company specialized in hearing disorders. Based in Montpellier, Boston, Paris, and Copenhagen, CILcare has become the one-stop partner for pharmaceutical industries, biotechs, medtechs, veterinary & nutraceutical companies, developing novel therapies for people with ear disorders. CILcare designs and performs pharmacokinetics, efficacy, and GLP ototoxicity studies to assess drugs, medical devices, cell & gene therapies, health food ingredients, on hearing loss, tinnitus, ototoxicity, and otitis.